Clinical trials: Kohlmeier Degos Disease With Neurologic Involvement, open to volunteers
Kohlmeier-Degos Disease, Malignant Atrophic Papulosis
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
Background: Kohlmeier-Degos (KD) is a rare disease that causes inflammation and blood clots, leading to blockages in small blood vessels.
- Conditions
- Kohlmeier-Degos Disease, Malignant Atrophic Papulosis, Degos Disease, Papulosis, Malignant Atrophic
- Trial name
- NCT06923072
- Testing
- Baricitinib
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)